List of therapeutic monoclonal antibodies

Therapeutic, diagnostic and preventive monoclonal antibodies are clones of a single parent cell. When used as drugs, the International Nonproprietary Names (INNs) end in -mab. The remaining syllables of the INNs, as well as the column Source, are explained in Nomenclature of monoclonal antibodies.

The abbreviations in the column Type are as follows:

This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.

NameBrand nameTypeSourceTargetApprovedUse
3F8mabmouseGD2 gangliosideneuroblastoma
AbagovomabmabmouseCA-125 (imitation)ovarian cancer
AbciximabReoProFabchimericCD41 (integrin alpha-IIb)Yplatelet aggregation inhibitor
AbituzumabmabhumanizedCD51cancer
AbrezekimabFabhumanizedIL-13
Abrilumabmabhumanintegrin α4 β7inflammatory bowel disease, ulcerative colitis, Crohn's disease
ActoxumabmabhumanClostridioides difficileClostridioides difficile colitis
AdalimumabHumiramabhumanTNF-αYrheumatoid arthritis, Crohn's disease, plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, hemolytic disease of the newborn
AdecatumumabmabhumanEpCAMprostate and breast cancer
AducanumabAduhelmmabhumanAmyloid betaYAlzheimer's disease
AfasevikumabmabhumanIL-17A, IL-17Fmultiple sclerosis
AfelimomabF(ab')2mouseTNF-αsepsis
Alacizumab pegolF(ab')2humanizedVEGFR2cancer
AlemtuzumabLemtrada, CampathmabhumanizedCD52Ymultiple sclerosis
AlirocumabPraluentmabhumanPCSK9Yhypercholesterolemia
Altumomab pentetateHybri-ceakermabmouseCarcinoembryonic antigen (CEA)colorectal cancer (diagnosis)
Amatuximabmabchimericmesothelincancer
AmivantamabRybrevantBsAbhumanEpidermal growth factor receptor (EGFR), cMetYnon-small cell lung cancer
Anatumomab mafenatoxFabmouseTumor-associated glycoprotein 72 (TAG-72)non-small cell lung cancer
Andecaliximabmabchimericgelatinase Bgastric cancer or gastroesophageal junction adenocarcinoma
Anetumab ravtansinemabhumanmesothelin (MSLN)cancer
AnifrolumabSaphnelomabhumanIFN-α/β receptorYsystemic lupus erythematosus
AnsuvimabEbangamabhumanEbola virus glycoproteinYtreatment of Zaire ebolavirus (Ebola virus)
Anrukinzumab
(= IMA-638)
mabhumanizedIL-13asthma
ApolizumabmabhumanizedHLA-DRhematological cancers
Aprutumab ixadotinmabhumanFGFR2
ArcitumomabCEA-ScanFab'mouseCarcinoembryonic antigen (CEA)gastrointestinal cancers (diagnosis)
Ascrinvacumabmabhumanactivin receptor-like kinase 1cancer
AselizumabmabhumanizedL-selectin (CD62L)severely injured patients
AtezolizumabTecentriqmabhumanizedPD-L1Ycancer
AtidortoxumabmabhumanStaphylococcus aureus alpha toxin
AtinumabmabhumanRTN4
AtoltivimabmabhumanEbola virus glycoproteinpart of Atoltivimab/maftivimab/odesivimab for treatment of Zaire ebolavirus (Ebola virus)
Atoltivimab/maftivimab/odesivimabInmazebmabhumanYtreatment of Zaire ebolavirus (Ebola virus)
AtorolimumabmabhumanRhesus factorhemolytic disease of the newborn
AvelumabBavenciomabhumanPD-L1Ycancer
AxatilimabNiktimvomabhumanizedCSF1RYchronic graft-versus-host disease
Azintuxizumab vedotinmabchimeric/
humanized
CD319cancer
Bamlanivimabmabhumanspike protein receptor binding domain (RBD) of SARS-CoV-2US emergency use authorization (EUA) when used with etesevimabCOVID-19
Bapineuzumabmabhumanizedβ-amyloidAlzheimer's disease
BasiliximabSimulectmabchimericCD25 (α chain of IL-2 receptor)Yprevention of organ transplant rejections
Bavituximabmabchimericphosphatidylserinecancer, viral infections
BCD-100humanPD-1melanoma
Bebtelovimabmabhumanspike protein receptor binding domain (RBD) of SARS-CoV-2US emergency use authorization (EUA)COVID-19
BectumomabLymphoScanFab'mouseCD22non-Hodgkin's lymphoma (detection)
BedinvetmabLibrelamabveterinarynerve growth factor (NGF)Ypain associated with osteoarthritis in dogs
BegelomabmabmouseDPP4
Belantamab mafodotinBlenrepmabhumanizedB-cell maturation antigen (BCMA)Y (Withdrawn)relapsed or refractory multiple myeloma
BelimumabBenlystamabhumanB-cell activating factor (BAFF)Ysystemic lupus erythematosus without renal or CNS involvement
BemarituzumabmabhumanizedFGFR2gastric cancer or gastroesophageal junction adenocarcinoma
BenralizumabFasenramabhumanizedCD125Yasthma
BerlimatoxumabmabhumanStaphylococcus aureus bi-component leukocidin
BermekimabXilonixmabhumanIL-1αcolorectal cancer
BersanlimabmabhumanICAM-1
BertilimumabmabhumanCCL11 (eotaxin-1)severe allergic disorders
BesilesomabScintimunmabmouseCarcinoembryonic antigen (CEA)-related antigeninflammatory lesions and metastases (detection)
BevacizumabAvastinmabhumanizedVEGF-AYmetastatic cancer, retinopathy of prematurity
BezlotoxumabZinplavamabhumanClostridioides difficileYClostridioides difficile colitis
BiciromabFibriScintFab'mousefibrin II, beta chainthromboembolism (diagnosis)
BimagrumabmabhumanACVR2Bmyostatin inhibitor
BimekizumabBimzelxmabhumanizedIL-17A, IL-17F, IL-17AFYpsoriasis
Birtamimabmabchimericserum amyloid A proteinamyloidosis
BivatuzumabmabhumanizedCD44 v6squamous cell carcinoma
BleselumabmabhumanCD40organ transplant rejection
BlinatumomabBlincytoBiTEmouseCD19Ypre-B Acute lymphoblastic leukemia (ALL) (CD19+)
BlontuvetmabBlontressmabveterinaryCD20
BlosozumabmabhumanizedSOSTosteoporosis
BococizumabmabhumanizedPCSK9dyslipidemia
BrazikumabmabhumanIL-23Crohn's disease
Brentuximab vedotinAdcentrismabchimericCD30 (TNFRSF8)YHodgkin's lymphoma, anaplastic large-cell lymphoma
BriakinumabmabhumanIL-12, IL-23psoriasis, rheumatoid arthritis, inflammatory bowel diseases, multiple sclerosis
BrodalumabSiliqmabhumanIL-17YPlaque psoriasis
BrolucizumabBeovuscFvhumanizedvascular endothelial growth factor A (VEGFA)Ywet age-related macular degeneration
BrontictuzumabmabhumanizedNotch 1cancer
BurosumabCrysvitamabhumanFGF 23YX-linked hypophosphatemia
CabiralizumabmabhumanizedCSF1Rmetastatic pancreatic cancer
Camidanlumab tesirinemabhumanCD25 (α chain of IL-2 receptor)B-cell Hodgkin's lymphoma, non-Hodgkin lymphoma, acute lymphoblastic leukemia, acute myeloid leukemia
CamrelizumabmabhumanizedPD-1hepatocellular carcinoma
CanakinumabIlarismabhumanIL-1Ycryopyrin-associated periodic syndrome, Yao's Syndrome, Adult Onset Still's Disease
Cantuzumab mertansinemabhumanizedCanAg (a glycoform of MUC1)colorectal cancer etc.
Cantuzumab ravtansinemabhumanizedCanAg (a glycoform of MUC1)cancers
CaplacizumabCablivisdAbhumanizedVWFYthrombotic thrombocytopenic purpura, thrombosis
Casirivimabmabhumanspike protein receptor binding domain (RBD) of SARS-CoV-2Yes when used with imdevimabCOVID-19
CapromabProstascintmabmouseGlutamate carboxypeptidase IIYprostate cancer (detection)
CarlumabmabhumanMCP-1oncology/immune indications
Carotuximabmabchimericendoglinangiosarcoma
CatumaxomabRemovab3functrat/mouse hybridEpCAM, CD3Yovarian cancer, malignant ascites, gastric cancer
cBR96-doxorubicin immunoconjugatemabhumanizedLewis-Y antigencancer
CedelizumabmabhumanizedCD4prevention of organ transplant rejections, treatment of autoimmune diseases
CemiplimabLibtayomabhumanPD-1Ycutaneous squamous cell carcinoma
Cergutuzumab amunaleukinmabhumanizedIL-2cancer
Certolizumab pegolCimziaFab'humanizedTNF-αYCrohn's disease, rheumatoid arthritis, axial spondyloarthritis, psoriasis arthritis
CetrelimabmabhumanPD-1cancer
CetuximabErbituxmabchimericEpidermal growth factor receptor (EGFR)Ymetastatic colorectal cancer and head and neck cancer
CibisatamabmabhumanizedCEACAM5cancer
Cilgavimabmabhumanspike protein receptor binding domain (RBD) of SARS-CoV-2US emergency use authorization (EUA) when used with tixagevimabCOVID-19
CirmtuzumabhumanizedROR1chronic lymphocytic leukemia
Citatuzumab bogatoxFabhumanizedEpCAMovarian cancer and other solid tumors
CixutumumabmabhumanIGF-1 receptor (CD221)solid tumors
ClazakizumabmabhumanizedIL-6rheumatoid arthritis
ClenoliximabmabchimericCD4rheumatoid arthritis
ClesrovimabEnflonsiamabhumanrespiratory syncytial virus F proteinYrespiratory syncytial virus (prevention)
Clivatuzumab tetraxetanhPAM4-CidemabhumanizedMUC1pancreatic cancer
Codrituzumabmabhumanizedglypican 3cancer
Cofetuzumab pelidotinmabhumanizedPTK7cancer
Coltuximab ravtansinemabchimericCD19cancer
ConatumumabmabhumanTRAIL-R2cancer
ConcizumabAlhemomabhumanizedtissue factor pathway inhibitor (TFPI)Ybleeding with hemophilia
CosfroviximabZMappmabchimericebolavirus glycoproteinEbola virus
CosibelimabUnloxcytmabhumanProgrammed death ligand-1 (PD-L1)Ycutaneous squamous cell carcinoma
Crenezumabmabhumanizedβ-amyloid (1-40 and 1-42)Alzheimer's disease
CrizanlizumabAdakveomabhumanizedselectin PYsickle-cell disease
Crotedumabmabhumanglucagon receptor (GCGR)diabetes
CrovalimabPiaskymabhumanizedC5Yparoxysmal nocturnal hemoglobinuria
CR6261mabhumanHemagglutinin (influenza)infectious disease/influenza A
CusatuzumabmabhumanizedCD70cancer
DacetuzumabmabhumanizedCD40hematologic cancers
DaclizumabZenapaxmabhumanizedCD25 (α chain of IL-2 receptor)Yprevention of organ transplant rejections, multiple sclerosis
DalotuzumabmabhumanizedIGF-1 receptor (CD221)cancer etc.
Dapirolizumab pegolmabhumanizedCD154 (CD40L)
DaratumumabDarzalexmabhumanCD38Ymultiple myeloma
DectrekumabmabhumanIL-13
DemcizumabmabhumanizedDLL4cancer
Denintuzumab mafodotinmabhumanizedCD19cancer
DenosumabProliamabhumanRANKLYosteoporosis, bone metastases etc.
Depatuxizumab mafodotinmabchimeric/
humanized
EGFRglioblastoma
Derlotuximab biotinmabchimerichistone complexrecurrent glioblastoma multiforme
DetumomabmabmouseB-lymphoma celllymphoma
Dezamizumabmabhumanizedserum amyloid P component
DinutuximabUnituxinmabchimericGD2 gangliosideYneuroblastoma
Dinutuximab betaQarzibamabchimericGD2 gangliosideYneuroblastoma
DiridavumabmabhumanHemagglutinin (influenza)influenza A
DivozilimabIvlizimabhumanizedCD20Y (Russia)multiple sclerosis
DomagrozumabmabhumanizedGDF-8Duchenne muscular dystrophy
DonanemabKisunlamabhumanizedAmyloid betaYAlzheimer's disease
Dorlimomab aritoxF(ab')2mouse
DostarlimabJemperlimabhumanizedPCDP1Yendometrial cancer
DrozitumabmabhumanDR5cancer etc.
DS-8201humanizedHER2gastric or gastroesophageal junction adenocarcinoma
DuligotuzumabmabhumanizedERBB3 (HER3)testicular cancer
DupilumabDupixentmabhumanIL-4RαYatopic dermatitis, asthma, nasal polyps
DurvalumabImfinzimabhumanPD-L1Ycancer
DusigitumabmabhumanIGF-2B-cell malignancies
DuvortuxizumabscFvchimeric/
humanized
CD19, CD3Ecancer
EcromeximabmabchimericGD3 gangliosidemalignant melanoma
EculizumabSolirismabhumanizedC5Yparoxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome
Edobacomabmabmouseendotoxinsepsis caused by Gram-negative bacteria
EdrecolomabPanorexmabmouseEpCAMcolorectal carcinoma
EfalizumabRaptivamabhumanizedLFA-1 (CD11a)psoriasis (blocks T-cell migration)
EfungumabMycograbscFvhumanHsp90invasive Candida infection
EldelumabmabhumanCXCL10 (IP-10)Crohn's disease, ulcerative colitis
Elezanumabmabhumanrepulsive guidance molecule A (RGMA)spinal cord injury and multiple sclerosis
ElgemtumabmabhumanERBB3 (HER3)cancer
ElotuzumabEmplicitimabhumanizedSLAMF7Ymultiple myeloma
ElsilimomabmabmouseIL-6
EmactuzumabmabhumanizedCSF1Rcancer
EmapalumabGamifantmabhumanIFN-γYhemophagocytic lymphohistiocytosis
EmibetuzumabmabhumanizedHGFRcancer
EmicizumabHemlibraBsAbhumanizedactivated F9, F10Yhaemophilia A
Enapotamab vedotinmabhumanAXLcancer
EnavatuzumabmabhumanizedTWEAK receptorcancer etc.
Enfortumab vedotinPadcevmabhumannectin-4Yurothelial cancer
Enlimomab pegolmabmouseICAM-1 (CD54)
EnoblituzumabmabhumanizedCD276cancer
EnokizumabmabhumanizedIL-9asthma
EnoticumabmabhumanDLL4
EnsituximabmabchimericMUC5ACcancer
EpcoritamabEpkinlyBiTEhumanizedCD3, CD20Ydiffuse large B-cell lymphoma
Epitumomab cituxetanmabmouseepisialin
EpratuzumabmabhumanizedCD22cancer, systemic lupus erythematosus (SLE)
EptinezumabVyeptimabhumanizedcalcitonin gene-related peptideYmigraine
ErenumabAimovigmabhumancalcitonin gene-related peptide receptor (CGRP)Ymigraine
ErlizumabF(ab')2humanizedITGB2 (CD18)heart attack, stroke, traumatic shock
ErtumaxomabRexomun3functrat/mouse hybridHER2/neu, CD3Ybreast cancer etc.
EtaracizumabAbegrinmabhumanizedintegrin αvβ3Ymelanoma, prostate cancer, ovarian cancer etc.
Etesevimabmabhumanspike protein receptor binding domain (RBD) of SARS-CoV-2US emergency use authorization (EUA) when used with bamlanivimabCOVID-19
EtigilimabmabhumanizedTIGIT
Etrolizumabmabhumanizedintegrin β7inflammatory bowel disease
EvinacumabEvkeezamabhumanangiopoietin 3Ydyslipidemia
EvolocumabRepathamabhumanPCSK9Yhypercholesterolemia
Exbivirumabmabhumanhepatitis B surface antigenhepatitis B
FanolesomabNeutroSpecmabmouseCD15appendicitis (diagnosis)
FaralimomabmabmouseIFN receptor
FaricimabVabysmomabhumanizedVEGF-A and Ang-2Yangiogenesis, ocular vascular diseases
Farletuzumabmabhumanizedfolate receptor 1ovarian cancer
Fasinumabmabhumannerve growth factor (NGF)acute sciatic pain
FBTA05Lymphomun3functrat/mouse hybridCD20chronic lymphocytic leukaemia
Felvizumabmabhumanizedrespiratory syncytial virusrespiratory syncytial virus infection
FezakinumabmabhumanIL-22rheumatoid arthritis, psoriasis
Fibatuzumabmabhumanizedephrin receptor A3
FiclatuzumabmabhumanizedHepatocyte growth factor (HGF)cancer etc.
FigitumumabmabhumanIGF-1 receptor (CD221)adrenocortical carcinoma, non-small cell lung carcinoma etc.
FirivumabmabhumanHemagglutinin (influenza)
FlanvotumabmabhumanTYRP1 (glycoprotein 75)melanoma
FletikumabmabhumanIL-20rheumatoid arthritis
Flotetuzumabdi-scFvhumanizedIL-3 receptorhematological malignancies
FontolizumabHuZAFmabhumanizedIFN-γCrohn's disease etc.
ForalumabmabhumanCD3E
Foravirumabmabhumanrabies virus glycoproteinrabies (prophylaxis)
FremanezumabAjovymabhumanizedcalcitonin gene-related peptide alpha and betaYmigraine
FresolimumabmabhumanTGF-βidiopathic pulmonary fibrosis, focal segmental glomerulosclerosis, cancer
FrovocimabmabhumanizedPCSK9hypercholesterolemia
FrunevetmabSolensiamabveterinarynerve growth factor (NGF)Ypain associated with osteoarthritis in cats
Fulranumabmabhumannerve growth factor (NGF)pain
FutuximabmabchimericEpidermal growth factor receptor (EGFR)cancer
GalcanezumabEmgalitymabhumanizedcalcitoninYmigraine
GaliximabmabchimericCD80B-cell lymphoma
GancotamabscFvhumanHER2/neucancer
GanitumabmabhumanIGF-1 receptor (CD221)cancer
Gantenerumabmabhumanβ-amyloid (1-40 and 1-42)Alzheimer's disease
GaradacimabAndembrymabhumanCoagulation factor XIIaYhereditary angioedema
GatipotuzumabmabhumanizedMUC1cancer
GavilimomabmabmouseCD147 (basigin)graft versus host disease
GedivumabmabhumanHemagglutinin (influenza)
Gemtuzumab ozogamicinMylotargmabhumanizedCD33Yacute myelogenous leukemia
GevokizumabmabhumanizedIL-1βdiabetes etc.
GilvetmabmabveterinaryPCDC1
GimsilumabmabhumanCSF2rheumatoid arthritis
GirentuximabRencarexmabchimericcarbonic anhydrase 9 (CA-IX)clear cell renal cell carcinoma
Glembatumumab vedotinmabhumanGPNMBmelanoma, breast cancer
GlofitamabColumviBsAbhumanizedCD20, CD3Ydiffuse large B-cell lymphoma
GolimumabSimponimabhumanTNF-αYrheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis
GomiliximabmabchimericCD23 (IgE receptor)allergic asthma
Gosuranemabmabhumanizedtau proteinprogressive supranuclear palsy
GuselkumabTremfyamabhumanIL-23Ypsoriasis
IanalumabmabhumanBAFF-Rautoimmune hepatitis
IbalizumabTrogarzomabhumanizedCD4YHIV infection
SintilimabhumanPD-1squamous cell non-small cell lung cancer
Ibritumomab tiuxetanZevalinmabmouseCD20Ynon-Hodgkin's lymphoma
IcrucumabmabhumanVEGFR-1cancer etc.
IdarucizumabPraxbindmabhumanizeddabigatranYreversal of anticoagulant effects of dabigatran
IfabotuzumabmabhumanizedEPHA3glioblastoma multiforme
IgovomabIndimacis-125F(ab')2mouseCA-125ovarian cancer (diagnosis)
Iladatuzumab vedotinmabhumanizedCD79Bcancer
Imalumabmabhumanmacrophage migration inhibitory factor (MIF)cancer
Imaprelimabmabhumanizedmelanoma cell adhesion molecule (MCAM)
ImciromabMyoscintmabmousecardiac myosinYcardiac imaging
Imdevimabmabhumanspike protein receptor binding domain (RBD) of SARS-CoV-2Yes when used with casirivimabCOVID-19
ImgatuzumabmabhumanizedEpidermal growth factor receptor (EGFR)cancer
Inclacumabmabhumanselectin Pcardiovascular disease
Indatuximab ravtansinemabchimericSDC1cancer
Indusatumab vedotinmabhumanGUCY2Ccancer
InebilizumabUpliznamabhumanizedCD19Ycancer, systemic sclerosis, multiple sclerosis
InfliximabRemicademabchimericTNF-αYrheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis, Crohn's disease, ulcerative colitis
IntetumumabmabhumanCD51solid tumors (prostate cancer, melanoma)
InolimomabmabmouseCD25 (α chain of IL-2 receptor)graft versus host disease
Inotuzumab ozogamicinBesponsamabhumanizedCD22YAcute lymphoblastic leukemia (ALL)
IpilimumabYervoymabhumanCD152Ymelanoma
Iomab-BmouseCD45ablation of bone marrow
IratumumabmabhumanCD30 (TNFRSF8)Hodgkin's lymphoma
IsatuximabSarclisamabchimericCD38Ymultiple myeloma
IscalimabmabhumanCD40
IstiratumabmabhumanIGF-1 receptor (CD221)advanced solid tumors
ItolizumabAlzumabmabhumanizedCD6Ypsoriasis
IxekizumabTaltzmabhumanizedIL-17AYautoimmune diseases
KappaMABmabmouseKappa Myeloma Antigen (KMA)multiple myeloma
KeliximabmabchimericCD4chronic asthma
LabetuzumabCEA-CidemabhumanizedCarcinoembryonic antigen (CEA)colorectal cancer
LacnotuzumabmabhumanizedCSF1, macrophage colony stimulating factor (MCSF)cancer
Ladiratuzumab vedotinmabhumanizedLIV-1cancer
LampalizumabFabhumanizedComplement factor D (CFD)geographic atrophy secondary to age-related macular degeneration
LanadelumabTakhzyromabhumankallikreinYangioedema
LandogrozumabmabhumanizedGDF-8muscle wasting disorders
Laprituximab emtansinemabchimericepidermal growth factor receptor (EGFR)
Larcaviximabmabchimericebolavirus glycoproteinEbola virus
LebrikizumabEbglyssmabhumanizedIL-13eczema
LecanemabLeqembimabhumanizedβ-amyloidYAlzheimer's disease
LemalesomabmabmouseNCA-90 (granulocyte antigen)diagnostic agent
LendalizumabmabhumanizedC5
Lenvervimabmabhumanizedhepatitis B surfage antigenhepatitis B
LenzilumabmabhumanCSF2chronic myelomonocytic leukemia and juvenile myelomonocytic leukemia
LerdelimumabmabhumanTGF-β2reduction of scarring after glaucoma surgery
LeronlimabmabhumanizedCCR5breast cancer, HIV
LesofavumabmabhumanHemagglutinin (influenza)
LetolizumabscFvhumanizedtumor necrosis factor related activation protein (TRAP)inflammatory diseases
LexatumumabmabhumanTRAIL-R2cancer
Libivirumabmabhumanhepatitis B surface antigenhepatitis B
Lifastuzumab vedotinmabhumanizedphosphate-sodium co-transportercancer
LigelizumabmabhumanizedIGHEsevere asthma, chronic spontaneous urticaria
Loncastuximab tesirineZynlontamabchimericCD19Yrelapsed or refractory large B-cell lymphoma
Losatuxizumab vedotinmabchimeric/
humanized
epidermal growth factor receptor (EGFR), ERBB1 (HER1)cancer
Lilotomab satetraxetanmabmouseCD37cancer
LintuzumabmabhumanizedCD33cancer
LinvoseltamabBsAbhumanCD3 and B-cell maturation antigen (BCMA)multiple myeloma
LirilumabmabhumanKIR2Dsolid and hematological cancers
LodelcizumabmabhumanizedPCSK9hypercholesterolemia
LokivetmabCytopointmabveterinaryCanis lupus familiaris IL31Yclinical signs of atopic dermatitis in dogs
Lorvotuzumab mertansinemabhumanizedCD56cancer
LucatumumabmabhumanCD40multiple myeloma, non-Hodgkin's lymphoma, Hodgkin's lymphoma
Lulizumab pegolmabhumanizedCD28autoimmune diseases
LumiliximabmabchimericCD23 (IgE receptor)chronic lymphocytic leukemia
LumretuzumabmabhumanizedERBB3 (HER3)cancer
Lupartumabmabhuman
Lupartumab amadotinmabhumanLYPD3
LutikizumabmabhumanizedIL-1α
Maftivimabmabhumanpart of Atoltivimab/maftivimab/odesivimab for treatment of Zaire ebolavirus (Ebola virus)
MapatumumabmabhumanTRAIL-R1cancer
MargetuximabMargenzamabhumanizedHER2Ybreast cancer
MarstacimabHympavzimabhumantissue factor pathway inhibitor (TFPI)Ybleeding with hemophilia
MaslimomabmouseT-cell receptor
MavrilimumabmabhumanGMCSF receptor α-chainrheumatoid arthritis
MatuzumabmabhumanizedEpidermal growth factor receptor (EGFR)colorectal, lung and stomach cancer
MepolizumabNucalamabhumanizedIL-5Yasthma and white blood cell diseases
MetelimumabmabhumanTGF-β1systemic scleroderma
MilatuzumabmabhumanizedCD74multiple myeloma and other hematological malignancies
MinretumomabmabmouseTAG-72tumor detection (and therapy?)
MirikizumabOmvohmabhumanizedIL-23Yulcerative colitis
Mirvetuximab soravtansineElaheremabchimericfolate receptor alphaYovarian cancer
MitumomabmabmouseGD3 gangliosidesmall cell lung carcinoma
ModotuximabmabchimericEGFR extracellular domain IIIcancer
MogamulizumabPoteligeomabhumanizedCCR4Yadult T-cell leukemia/lymphoma
MonalizumabmabhumanizedNKG2Arheumatoid arthritis, gynecologic malignancies, and other cancers
MorolimumabmabhumanRhesus factor
MosunetuzumabLunsumioBiTEhumanizedCD3E, MS4A1, CD20Yfollicular lymphoma
MotavizumabNumaxmabhumanizedrespiratory syncytial virusrespiratory syncytial virus (prevention)
Moxetumomab pasudotoxLumoxitimabmouseCD22Yhairy cell leukemia
Muromonab-CD3Orthoclone OKT3mabmouseCD3prevention of organ transplant rejections
Nacolomab tafenatoxFabmouseC242 antigencolorectal cancer
NamilumabmabhumanCSF2
Naptumomab estafenatoxFabmouse5T4non-small cell lung carcinoma, renal cell carcinoma
Naratuximab emtansinemabchimericCD37
NarnatumabmabhumanMST1R (aka RON)cancer
NatalizumabTysabrimabhumanizedintegrin α4Ymultiple sclerosis, Crohn's disease
Navicixizumabmabchimeric/
humanized
DLL4 and VEGFAcancer
NavivumabmabhumanHemagglutinin (influenza)
NaxitamabDanyelzahumanizedc-MetYhigh-risk neuroblastoma and refractory osteomedullary disease
Nebacumabmabhumanendotoxinsepsis
NecitumumabPortrazzamabhumanEpidermal growth factor receptor (EGFR)Ynon-small cell lung carcinoma
NemolizumabNemluviomabhumanizedIL-31 receptor Aeczema
NEOD001humanizedamyloidprimary systemic amyloidosis
NerelimomabmabmouseTNF-α
Nesvacumabmabhumanangiopoietin 2cancer
NetakimabEfleiramabhumanizedIL-17AY (Russia)plaque psoriasis, psoriatic arthritis, ankylosing spondylitis
NimotuzumabBioMab-EGFR, Theracim, Theralocmabhumanizedepidermal growth factor receptor (EGFR)Ysquamous cell carcinoma, head and neck cancer, nasopharyngeal cancer, glioma
NipocalimabImaavymabhumanNeonatal fragment crystallizable receptorYgeneralized myasthenia gravis
NirsevimabBeyfortusmabhumanRSV fusion glycoproteinrespiratory syncytial virus
NivolumabOpdivomabhumanPD-1Ycancer
Nofetumomab merpentanVerlumaFabmousecancer (diagnosis)
ObiltoxaximabAnthimmabchimericBacillus anthracis anthraxYBacillus anthracis spores
ObinutuzumabGazyvamabhumanizedCD20Ychronic lymphatic leukemia
OcaratuzumabmabhumanizedCD20cancer
OcrelizumabOcrevusmabhumanizedCD20Ymultiple sclerosis
Odesivimabmabhumanpart of Atoltivimab/maftivimab/odesivimab for treatment of Zaire ebolavirus (Ebola virus)
OdulimomabmabmouseLFA-1 (CD11a)prevention of organ transplant rejections, immunological diseases
OfatumumabArzerra, KesimptamabhumanCD20Ychronic lymphocytic leukemia, multiple sclerosis
OlaratumabLartruvomabhumanPDGFRAYcancer
Oleclumabmabhuman5'-nucleotidasepancreatic and colorectal cancer
Olendalizumabmabhumanizedcomplement C5asystemic lupus erythematosus, lupus nephritis, acute graft-versus-host disease
OlokizumabmabhumanizedIL-6rheumatoid arthritis
OmalizumabXolairmabhumanizedIgE Fc regionYallergic asthma, chronic spontaneous urticaria
OmburtamabmabmouseCD276cancer
OMS721humanMASP-2atypical hemolytic uremic syndrome
OnartuzumabFabhumanizedhuman scatter factor receptor kinasecancer
Ontuxizumabmabchimeric/
humanized
TEM1cancer
OnvatilimabmabhumanVISTA (protein) (VSIR)
OpicinumabmabhumanLINGO-1multiple sclerosis
Oportuzumab monatoxViciniumscFvhumanizedEpCAMbladder cancer
OregovomabOvaRexmabmouseCA-125ovarian cancer
OrticumabmabhumanoxLDL
Otelixizumabmabchimeric/
humanized
CD3diabetes mellitus type 1
OtilimabmabhumanGMCSFosteoarthritis, rheumatoid arthritis
OtlertuzumabmabhumanizedCD37cancer
OxelumabmabhumanOX-40asthma
OzanezumabmabhumanizedNOGO-AALS and multiple sclerosis
OzoralizumabmabhumanizedTNF-αinflammation
Pagibaximabmabchimericlipoteichoic acidsepsis (Staphylococcus)
PalivizumabSynagis, AbbosynagismabhumanizedF protein of respiratory syncytial virusYrespiratory syncytial virus (prevention)
Pamrevlumabmabhumanconnective tissue growth factor (CTGF)idiopathic pulmonary fibrosis (IPF), pancreatic cancer
PanitumumabVectibixmabhumanepidermal growth factor receptor (EGFR)Ycolorectal cancer
Pankomabmabhumanizedtumor specific glycosylation of MUC1ovarian cancer
PanobacumabmabhumanPseudomonas aeruginosaPseudomonas aeruginosa infection
ParsatuzumabmabhumanizedEGFL7cancer
PascolizumabmabhumanizedIL-4asthma
Pasotuxizumabmabchimeric/
humanized
folate hydrolasecancer
Pateclizumabmabhumanizedlymphotoxin alpha (LTA)TNF
PatritumabmabhumanERBB3 (HER3)cancer
PDR001humanizedPD-1melanoma
PembrolizumabKeytrudamabhumanizedPD-1Ymelanoma and other cancers
PemivibartPemgardamabhumanspike protein receptor binding domain (RBD) of SARS-CoV-2US emergency use authorization (EUA)COVID-19
PemtumomabTheragynmouseMUC1cancer
PenpulimabmabPD-1Ycancer
PerakizumabmabhumanizedIL-17Aarthritis
PertuzumabPerjetamabhumanizedHER2/neuYcancer
PexelizumabscFvhumanizedC5reduction of side effects of cardiac surgery
PidilizumabmabhumanizedPD-1cancer and infectious diseases
Pinatuzumab vedotinmabhumanizedCD22cancer
Pintumomabmabmouseadenocarcinoma antigenadenocarcinoma (imaging)
PlaculumabmabhumanTNFpain and inflammatory diseases
PozelimabVeopozmabhumanC5YCHAPLE disease
PrezalumabmabhumanTNF
PlozalizumabmabhumanizedCCR2diabetic nephropathy and arteriovenous graft patency
Pogalizumabmabhumanizedtumor necrosis factor receptor (TNFR) superfamily member 4
Polatuzumab vedotinPolivymabhumanizedCD79BYdiffuse large B-cell lymphoma
Ponezumabmabhumanizedβ-amyloidAlzheimer's disease
PorgaviximabmabchimericZaire ebolavirus glycoproteinEbola virus disease
PrasinezumabmabhumanizedAlpha-synucleinParkinson's disease
Prezalizumabmabhumanizedinducible T-cell co-stimulatory ligand (ICOSL)
PriliximabmabchimericCD4Crohn's disease, multiple sclerosis
PritoxaximabmabchimericE. coli shiga toxin type-1
Pritumumabmabhumanvimentinbrain cancer
PRO 140humanizedCCR5HIV infection
QuilizumabmabhumanizedIGHEasthma
RacotumomabVaxiramabmouseNGNA gangliosideYnon-small cell lung cancer
Radretumabmabhumanfibronectin extra domain-Bcancer
Rafivirumabmabhumanrabies virus glycoproteinrabies (prophylaxis)
RalpancizumabmabhumanizedPCSK9dyslipidemia
RamucirumabCyramzamabhumanVEGFR2Ysolid tumors
RanevetmabmabveterinaryNGFosteoarthritis in dogs
RanibizumabLucentisFabhumanizedVEGF-AYmacular degeneration (wet form)
Raxibacumabmabhumananthrax toxin, protective antigenYanthrax (prophylaxis and treatment)
RavagalimabmabhumanizedCD40Crohn's disease
RavulizumabUltomirismabhumanizedC5Yparoxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome
Refanezumabmabhumanizedmyelin-associated glycoproteinrecovery of motor function after stroke
Regavirumabmabhumancytomegalovirus glycoprotein Bcytomegalovirus infection
RegdanvimabRegkironamabhumanspike protein receptor binding domain (RBD) of SARS-CoV-2YCOVID-19
RelatlimabmabhumanLAG3melanoma
RemtolumabmabhumanIL-17A, TNF
ReslizumabCinqairmabhumanizedIL-5Yinflammations of the airways, skin and gastrointestinal tract
RetifanlimabZynyzmabhumanizedPD-1YMerkel cell carcinoma
Rilotumumabmabhumanhepatocyte growth factor (HGF)solid tumors
RinucumabmabhumanPDGFRBneovascular age-related macular degeneration
RisankizumabSkyrizimabhumanizedIL-23AYCrohn's disease, psoriasis, psoriatic arthritis, and asthma
RituximabMabThera, RituxanmabchimericCD20Ylymphomas, leukemias, some autoimmune disorders
Rivabazumab pegolmabhumanizedPseudomonas aeruginosa type III secretion system
RobatumumabmabhumanIGF-1 receptor (CD221)cancer
RmabRabiShieldhumanrabies virus G glycoproteinYpost-exposure prophylaxis of rabies
RoledumabmabhumanRHD (gene) (RHD)Rh disease
Romilkimabmabchimeric/
humanized
IL-13
RomosozumabEvenitymabhumanizedsclerostinYosteoporosis
RontalizumabmabhumanizedIFN-αsystemic lupus erythematosus
Rosmantuzumabmabhumanizedroot plate-specific spondin 3cancer
Rovalpituzumab tesirinemabhumanizedDLL3small cell lung cancer
RovelizumabLeukArrestmabhumanizedCD11, CD18Yhaemorrhagic shock etc.
RozanolixizumabRystiggomabchimeric/
humanized
FCGRTY myasthenia gravis
RuplizumabAntovamabhumanizedCD154 (CD40L)Yrheumatic diseases
SA237humanizedIL-6 receptorneuromyelitis optica and neuromyelitis optica spectrum disorders
Sacituzumab govitecanTrodelvymabhumanizedTROP-2Ytriple-negative breast cancer
SamalizumabmabhumanizedCD200cancer
Samrotamab vedotinmabchimeric/
humanized
LRRC15cancer
SarilumabKevzaramabhumanIL-6Yrheumatoid arthritis, ankylosing spondylitis
SatralizumabEnspryngmabhumanizedIL-6 receptorYneuromyelitis optica
Satumomab pendetidemabmouseTAG-72cancer (diagnosis)
SecukinumabCosentyxmabhumanIL-17AYuveitis, rheumatoid arthritis psoriasis
SelicrelumabmabhumanCD40
SeribantumabmabhumanERBB3 (HER3)cancer
SetoxaximabmabchimericE. coli shiga toxin type-2
Setrusumabmabhumansclerostin (SOST)
Sevirumabhumancytomegaloviruscytomegalovirus infection
SibrotuzumabmabhumanizedFAP (gene) (FAP)cancer
SGN-CD19AmabhumanizedCD19acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma
SHP647humanmucosal addressin cell adhesion moleculeCrohn's disease
SifalimumabmabhumanIFN-αsystemic lupus erythematosus (SLE), dermatomyositis, polymyositis
SiltuximabSylvantmabchimericIL-6Ycancer
SimtuzumabmabhumanizedLOXL2fibrosis
SipavibartKavigalemabhumanspike protein receptor binding domain (RBD) of SARS-CoV-2YCOVID-19
SiplizumabmabhumanizedCD2psoriasis, graft-versus-host disease (prevention)
Sirtratumab vedotinmabhumanSLITRK6cancer
SirukumabmabhumanIL-6rheumatoid arthritis
Sofituzumab vedotinmabhumanizedCA-125ovarian cancer
Solanezumabmabhumanizedβ-amyloidAlzheimer's disease
SolitomabBiTEmouseEpCAMgastrointestinal, lung, and other cancers
Sonepcizumabhumanizedsphingosine-1-phosphatechoroidal and retinal neovascularization
Sontuzumabmabhumanizedepisialin
SotrovimabXevudymabhumanspike protein receptor binding domain (RBD) of SARS-CoV-2YCOVID-19
SpartalizumabmabhumanizedPD-1melanoma
SpesolimabSpevigomabhumanizedInterleukin 36 receptor (IL1RL2/IL1RAP)Ygeneralized pustular psoriasis (GPP)
Stamulumabmabhumanmyostatinmuscular dystrophy
SugemalimabmabhumanPD-1non-small-cell lung cancer
SulesomabLeukoScanFab'mouseNCA-90 (granulocyte antigen)osteomyelitis (imaging)
SuptavumabmabhumanRSVFRmedically attended lower respiratory disease
SutimlimabEnjaymomabchimeric/
humanized
complement component 1s (C1s)Ycold agglutinin disease
SuvizumabmabhumanizedHIV-1viral infections
SuvratoxumabmabhumanStaphylococcus aureus alpha toxinnosocomial pneumonia
TabalumabmabhumanB-cell activating factor (BAFF)B-cell cancers
Tacatuzumab tetraxetanAFP-Cidemabhumanizedalpha-fetoproteincancer
TadocizumabFabhumanizedintegrin αIIbβ3percutaneous coronary intervention
TafasitamabMonjuvimabhumanized
(from mouse)
CD19Yrelapsed or refractory diffuse large B-cell lymphoma
TalacotuzumabmabhumanizedCD123leukemia etc.
TalizumabmabhumanizedIgEallergic reaction
TalquetamabTalveyBsAbhumanizedGPRC5D, CD3Yrelapsed or refractory multiple myeloma
TamtuvetmabTactressmabveterinaryCD52
Tanezumabmabhumanizednerve growth factor (NGF)pain
Taplitumomab paptoxmabmouseCD19cancer
TarextumabmabhumanNotch receptorcancer
TarlatamabImdelltraBsAbhumanDLL3, CD3Ysmall cell lung cancer
Tavolimabmabchimeric/
humanized
CD134cancer
TeclistamabTecvayliBsAbhumanB-cell maturation antigen (BCMA), CD3Yrelapsed or refractory multiple myeloma
TefibazumabAurexismabhumanizedclumping factor AStaphylococcus aureus infection
Telimomab aritoxFabmouse
TelisotuzumabmabhumanizedHGFRcancer
Telisotuzumab vedotinmabhumanizedHGFRcancer
Tenatumomabmabmousetenascin Ccancer
TeneliximabmabchimericCD40autoimmune diseases and prevention of organ transplant rejection
TeplizumabTzieldmabhumanizedCD3Ydiabetes mellitus type 1
Tepoditamabmabhumandendritic cell-associated lectin 2cancer
TeprotumumabTepezzamabhumanIGF-1 receptor (CD221)Ythyroid eye disease
TesidolumabmabhumanC5
TetulomabmabhumanizedCD37cancer
TezepelumabTezspiremabhumanthymic stromal lymphopoietin (TSLP)Yasthma
TGN1412humanizedCD28chronic lymphocytic leukemia, rheumatoid arthritis
TibulizumabmabhumanizedB-cell activating factor (BAFF)autoimmune disorders
TildrakizumabIlumyamabhumanizedIL-23Yimmunologically mediated inflammatory disorders
TigatuzumabmabhumanizedTRAIL-R2cancer
TimigutuzumabmabhumanizedHER2cancer
TimolumabmabhumanAOC3
tiragolumabmabhuman
TiragotumabmabhumanTIGITcancer
TislelizumabmabhumanizedPCDC1, CD279non-small cell lung cancer
Tisotumab vedotinTivdakmabhumancoagulation factor IIIYrelapsed or refractory cervical cancer
Tixagevimabmabhumanspike protein receptor binding domain (RBD) of SARS-CoV-2US emergency use authorization (EUA) when used with cilgavimabCOVID-19
TNX-650humanizedIL-13Hodgkin's lymphoma
TocilizumabActemra, RoActemramabhumanizedIL-6 receptorYrheumatoid arthritis
TomuzotuximabmabhumanizedEpidermal growth factor receptor (EGFR), HER1cancer
ToralizumabmabhumanizedCD154 (CD40L)rheumatoid arthritis, lupus nephritis etc.
TosatoxumabmabhumanStaphylococcus aureus
TositumomabBexxarmouseCD20Yfollicular lymphoma
TovetumabmabhumanPDGFRAcancer
TralokinumabAdtralza, AdbrymabhumanIL-13Yatopic dermatitis
TrastuzumabHerceptinmabhumanizedHER2/neuYbreast cancer
Trastuzumab duocarmazineKadcylamabhumanizedHER2/neuYbreast cancer
Trastuzumab emtansineKadcylamabhumanizedHER2/neuYbreast cancer
TRBS07Ektomab3functGD2 gangliosidemelanoma
TregalizumabmabhumanizedCD4
TremelimumabImjudomabhumanCTLA-4Yhepatocellular carcinoma
Trevogrumabmabhumangrowth differentiation factor 8muscle atrophy due to orthopedic disuse and sarcopenia
Tucotuzumab celmoleukinmabhumanizedEpCAMcancer
Tuvirumabhumanhepatitis B viruschronic hepatitis B
UblituximabBriumvimabchimericCD20Ymultiple sclerosis, chronic lymphocytic leukemia
UlocuplumabmabhumanCXCR4 (CD184)hematologic malignancies
Urelumabmabhuman4-1BB (CD137)cancer etc.
UrtoxazumabmabhumanizedEscherichia colidiarrhoea caused by E. coli
UstekinumabStelaramabhumanIL-12, IL-23Ymultiple sclerosis, psoriasis, psoriatic arthritis
Utomilumabmabhuman4-1BB (CD137)diffuse large B-cell lymphoma
Vadastuximab talirinemabchimericCD33Acute myeloid leukemia
VanalimabmabhumanizedCD40
Vandortuzumab vedotinmabhumanizedSTEAP1cancer
VantictumabmabhumanFrizzled receptorcancer
Vanucizumabmabhumanizedangiopoietin 2cancer
VapaliximabmabchimericAOC3 (VAP-1)
VarisacumabmabhumanVEGF-Aangiogenesis
VarlilumabmabhumanCD27solid tumors and hematologic malignancies
VatelizumabmabhumanizedITGA2 (CD49b)
VedolizumabEntyviomabhumanizedintegrin α4 β7YCrohn's disease, ulcerative colitis
VeltuzumabmabhumanizedCD20non-Hodgkin's lymphoma
VepalimomabmabmouseAOC3 (VAP-1)inflammation
VesencumabmabhumanNRP1solid malignancies
VilobelimabGohibicmabchimericC5a receptor (C5a)Y (EU), and US emergency use authorization (EUA)COVID-19
VisilizumabNuvionmabhumanizedCD3Crohn's disease, ulcerative colitis
VobarilizumabscFvhumanizedIL-6 receptorinflammatory autoimmune diseases
Volociximabmabchimericintegrin α5β1solid tumors
VonlerolizumabmabhumanizedCD134cancer
VopratelimabmabhumanizedCD278, aka ICOS
Vorsetuzumab mafodotinmabhumanizedCD70cancer
VotumumabHumaSPECTmabhumantumor antigen CTAA16.88colorectal tumors
VunakizumabmabhumanizedIL-17A
XentuzumabmabhumanizedIGF-1, IGF-2?
XMAB-5574humanizedCD19diffuse large B-cell lymphoma
ZalutumumabmabhumanEpidermal growth factor receptor (EGFR)squamous cell carcinoma of the head and neck
ZanidatamabZiiheraBsAbhumanizedHER2, HER2Ybiliary tract cancer
ZanolimumabmabhumanCD4rheumatoid arthritis, psoriasis, T-cell lymphoma
ZatuximabmabchimericHER1cancer
ZenocutuzumabBizengriBsAbhumanizedHER2, ERBB3 (HER3)Ycancer
ZiralimumabmabhumanCD147 (basigin)
ZolbetuximabVyloymabchimericClaudin 18 Isoform 2Ygastric cancer
Zolimomab aritoxmabmouseCD5systemic lupus erythematosus, graft-versus-host disease